phenylsulfonylthioacetamide | 54334-57-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: phenylsulfonylthioacetamide
• 英文别名: 2-benzenesulfonyl-thioacetamide；benzenesulfonyl-thioacetic acid amide；Benzolsulfonyl-thioessigsaeure-amid；Phenylsulfon-thioessigsaeure-amid；2-(phenylsulfonyl)ethanethioamide；2-(benzenesulfonyl)ethanethioamide
• CAS: 54334-57-5
• 化学式: C₈H₉NO₂S₂
• 分子量: 215.297
• InChiKey: LMWIJZGZHDOVCX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  phenylsulfonylthioacetamide 以 乙醇 为溶剂， 反应 6.0h， 生成 2-benzenesulfonyl-N-phenyl-2-(4-phenyl-thiazol-2-yl)-acetamide
  参考文献：
  名称：

  ?-Keto sulfone derivatives

  摘要：

  DOI：

  10.1007/bf00474322
• 作为产物：
  描述：

  sodium benzenesulfonate 在 硫化氢 、 氨 作用下， 生成 phenylsulfonylthioacetamide
  参考文献：
  名称：

  Troeger; Hille, Journal fur praktische Chemie (Leipzig 1954), 1905, vol. <2> 71, p. 232

  摘要：

  DOI：

文献信息

• Pyrid-2-one derivatives and methods of use
  申请人：——

  公开号：US20040147561A1

  公开（公告）日：2004-07-29

  Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于治疗疾病，如细胞增殖或凋亡介导的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物，以及用于预防和治疗涉及中风、癌症等疾病和其他疾病或病况的药物组合物和方法。该主题发明还涉及制备此类化合物的方法，以及在这些过程中有用的中间体。
• Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors
  作者：Wenge Zhong、Hu Liu、Matthew R. Kaller、Charles Henley、Ella Magal、Thomas Nguyen、Timothy D. Osslund、David Powers、Robert M. Rzasa、Hui-Ling Wang、Weiya Wang、Xiaoling Xiong、Jiandong Zhang、Mark H. Norman

  DOI：10.1016/j.bmcl.2007.07.045

  日期：2007.10

  Using active site homology modeling between CDK5 and CDK2, we explored several different chemical series of potent CDK5 inhibitors. In this report, we describe the design, synthesis, and CDK5 inhibitory activities of quinolin-2(1H)-one derivatives.

  细胞周期蛋白依赖性激酶5（CDK5）是一种丝氨酸/苏氨酸蛋白激酶，其失调与许多神经退行性疾病（例如阿尔茨海默氏病，肌萎缩性侧索硬化症和缺血性中风）有关。使用CDK5和CDK2之间的活性位点同源性建模，我们探索了有效的CDK5抑制剂的几种不同化学系列。在此报告中，我们描述了喹啉2（1H）-one衍生物的设计，合成和CDK5抑制活性。
• Compounds and methods of use
  申请人：Norman H. Mark

  公开号：US20070032518A1

  公开（公告）日：2007-02-08

  Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于治疗细胞增殖或凋亡介导的疾病具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物、药物组成物以及用于预防和治疗中风、癌症等疾病和其他疾病或病况的方法。该发明还涉及制备这样的化合物的过程，以及在这样的过程中有用的中间体。
• Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria
  申请人：Georgia State University Research Foundation, Inc.

  公开号：EP2529793A2

  公开（公告）日：2012-12-05

  The present disclosure encompasses compounds and compositions that are useful as specific AI-2 antagonists for the control of bacterial quorum sensing. Although the AI-2 antagonists according to the present disclosure may not have bactericidal effect, their ability to attenuate virulence, drug resistance, and/or biofilm formation have therapeutic benefits. In addition, the AI-2 antagonists of the present disclosure can also be used as tools to probe bacterial AI-2 functions. The present disclosure also encompasses methods for inhibiting or attenuating microbial virulence, biofilm formation, and drug resistance. The methods are suitable for preventing bacteria from accruing and forming extensive biofilms that may be a health or hygiene hazard or a physical issue, such as in the blockage of water or fuel lines.

  本公开包括可作为特异性 AI-2 拮抗剂用于控制细菌法定人数感应的化合物和组合物。尽管本公开的 AI-2 拮抗剂可能不具有杀菌作用，但其减弱毒性、耐药性和/或生物膜形成的能力具有治疗效果。此外，本公开的 AI-2 拮抗剂还可用作探究细菌 AI-2 功能的工具。本公开内容还包括抑制或减弱微生物毒力、生物膜形成和耐药性的方法。这些方法适用于防止细菌积累和形成广泛的生物膜，这些生物膜可能会危害健康或卫生，或造成物理问题，如堵塞水管或燃油管。
• Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors
  作者：Matthew R. Kaller、Wenge Zhong、Charles Henley、Ella Magal、Thomas Nguyen、David Powers、Robert M. Rzasa、Weiya Wang、Xiaoling Xiong、Mark H. Norman

  DOI：10.1016/j.bmcl.2009.10.027

  日期：2009.12

  Cyclin-dependent kinase 5 (CDK5) is a serine-threonine protein kinase that plays a significant role in neuronal development. In association with p25, CDK5 abnormally phosphorylates a number of cellular targets involved in neurodegenerative disorders. Using active site homology and previous structure-activity relationships, a new series of potent CDK5 inhibitors was designed. This report describes the optimization of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.